Evicenter
P&T meetings

Tovorafenib (DAY101)

RAF-altered pediatric low-grade glioma requiring first-line systemic therapy

Also known as TAK-580
Regulatory submission
Not announced
Launch
Not announced
Last updated
155 sources

Product information and disease descriptionProduct descriptionProduct information

American hospital formulary service (AHFS), or other drug classification

2 evidence topics · 2 sources

AHFS drug class
FieldQuoted record
Brand name“Ojemda”
Drug class“Antineoplastic Agents”
ATC classification

“Pharmacotherapeutic group: Antineoplastic agent, protein kinase inhibitor, B-Raf serine-threonine kinase (RAF) inhibitor, ATC code: L01EC04” (opens the source at this quote in a new tab)